HIV-1 Tat membrane interactions probed using X-ray and neutron scattering, CD spectroscopy and MD simulations

Biochimica et Biophysica Acta - Biomembranes

Volumn 1838, Issue 12, 2014, Pages 3078-3087

  Akabori, Kiyotaka ^a   Huang, Kun ^b   Treece, Bradley W ^a   Jablin, Michael S ^a   Maranville, Brian ^c   Woll, Arthur ^d   Nagle, John F ^a   Garcia, Angel E ^b   Tristram Nagle, Stephanie ^a  

^a CARNEGIE MELLON UNIVERSITY   (United States)

^b RENSSELAER POLYTECHNIC INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

^d Cornell University ^*  (United States)

Author keywords

Lipid bilayer structure cell penetrating peptide; Low angle X ray scattering (LAXS); Membrane pore; Molecular dynamics (MD) simulations; Peptide translocation; Wide angle X ray scattering (WAXS)

Indexed keywords

EID: 84949117471     PISSN: 00052736     EISSN: 18792642     Source Type: Journal    
DOI: 10.1016/j.bbamem.2014.08.014     Document Type: Article

References (75)

1. R. Fischer, M. Fotin-Mleczek H. Hufnagel, R. Brock, Break on through to the other side-biophysics and cell biology shed light on cell-penetrating peptides, Chembiochem 6 (2005) 2126-2142.
2. A. Joliot, A. Prochiantz, Transduction peptides: from technology to physiology, Nat Cell Biol. 6 (2004) 189-196.
3. M. Lindgren, M. Hallbrink A. Prochiantz, U. Langel, Cell-penetrating peptides, Trends Pharmacol. Sci. 21 (2000) 99-103.
4. A.D. Frankel, C.O. Pabo, Cellular uptake of the tat protein from human immunodeficiency virus, Cell 55 (1988) 1189-1193.
5. M. Green, P.M. Loewenstein, Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein, Cell 55 (1988) 1179-1188.
6. E. Vives, P. Brodin, B. Lebleu, A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus, J. Biol. Chem 272 (1997) 16010-16017.
7. G. Ter-Avetisyan, G. Tunnemann, D. Nowak M. Nitschke, A. Herrmann, M. Drab, M.C. Cardoso, Cell entry of arginine-rich peptides is independent of endocytosis, J. Biol. Chem. 284 (2009) 3370-3378.
8. F. Duchardt, M. Fotin-Mleczek, H. Schwarz, R. Fischer, R. Brock, A comprehensive model for the cellular uptake of cationic cell-penetrating peptides, Traffic8 (2007)848-866.
9. G. Tunnemann, R.M. Martin, S. Haupt, C. Patsch, F. Edenhofer, M.C. Cardoso, Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells, Faseb J 20 (2006) 1775-1784.
10. A. Ziegler, P. Nervi, M. Durrenberger, J. Seelig, The cationic cell-penetrating peptide Cpp(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence, Biochemistry 44 (2005) 138-148.
11. J.S. Wadia, R.V. Stan, S.F. Dowdy, Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis, Nat. Med. 10 (2004) 310-315.
12. I.M. Kaplan, J.S. Wadia, S.F. Dowdy, Cationic TAT peptide transduction domain enters cells by macropinocytosis, J. Control. Release 102 (2005) 247-253.
13. DA. Mann, A.D. Frankel, Endocytosis and targeting of exogenous HIV-1 Tat protein, Embo J. 10 (1991) 1733-1739.
14. J.P. Richard, K. Melikov, H. Brooks, P. Prevot, B. Lebleu, L.V. Chernomordik, Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors, J. Biol. Chem. 280 (2005) 15300-15306.
15. S.W.Jones, R. Christison, K. Bundell, C.J. Voyce, S.M. Brockbank P. Newham, M.A. Lindsay, Characterisation of cell-penetrating peptide-mediated peptide delivery, Br. J. Pharmacol. 145 (2005) 1093-1102.
16. A. Vendeville, F. Rayne, A. Bonhoure, N. Bettache, P. Montcourrier, B. Beaumelle, HIV-1 Tat enters T cells using coated pits before translocating from acidified endosomes and eliciting biological responses, Mol. Biol. Cell 15 (2004) 2347-2360.
17. C. Foerg, U. Ziegler, J. Fernandez-Carneado, E. Giralt, R. Rennert, A.G. Beck-Sickinger, H.P. Merkle, Decoding the entry of two novel cell-penetrating peptides in HeLa cells: lipid raft-mediated endocytosis and endosomal escape, Biochemistry-Us 44 (2005) 72-81.
18. A. Fittipaldi, M. Giacca, Transcellular protein transduction using the Tat protein of HIV-1, Adv. Drug Deliv. Rev. 57 (2005) 597-608.
19. Y. Liu, M. Jones, C.M. Hingtgen, G.J. Bu, N. Laribee, R.E. Tanzi, R.D. Moir, A. Nath, J.J. He, Uptake of HIV-1 Tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands, Nat. Med. 6 (2000) 1380-1387.
20. V.P. Torchilin, R. Rammohan, V. Weissig, T.S. Levchenko, TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors, Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 8786-8791.
21. V.P. Torchilin, T.S. Levchenko, R. Rammohan, N. Volodina, B. Papahadjopoulos-Sternberg, G.G. D'Souza, Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes, Proc. Natl. Acad. Sci. U.S. A. 100 (2003) 1972-1977.
22. C. Rudolph, C. Plank, J. Lausier, U. Schillinger, R.H. Muller, J. Rosenecker, Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells, J. Biol. Chem. 278 (2003) 11411-11418.
23. A. Chauhan, A. Tikoo, A.K. Kapur, M. Singh, The taming of the cell penetrating domain of the HIV Tat: myths and realities, J. Control. Release 117 (2007) 148-162.
24. J.M. Sabatier, E. Vives, K. Mabrouk, A. Benjouad, H. Rochat, A. Duval, B. Hue, E. Bahraoui, Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1, J. Virol. 65 (1991) 961-967.
25. A. Mishra, V. D. Gordon, L. Yang, R. Coridan, G. C. Wong, HIVTAT forms pores inmem-branes by inducing saddle-splay curvature: potential role of bidentate hydrogen bonding, Angew. Chem. Int. Ed. Engl. 47 (2008) 2986-2989.
26. S.T. Yang, E. Zaitseva, L.V. Chernomordik, K. Melikov, Cell-penetrating peptide induces leaky fusion of liposomes containing late endosome-specific anionic lipid, Biophys. J. 99 (2010) 2525-2533.
27. P.E.G. Thoren, D. Persson, E.K. Esbjorner, M. Goksor, P. Lincoln, B. Norden, Membrane binding and translocation of cell-penetrating peptides, Biochemistry 43 (2004) 3471-3489.
28. S.D. Kramer, H. Wunderli-Allenspach, No entry for TAT(44-57) into liposomes and intact MDCK cells: novel approach to study membrane permeation of cell-penetrating peptides, Biochim. Biophys. Acta Biomembr. 1609 (2003) 161-169.
29. C. Ciobanasu, J.P. Siebrasse, U. Kubitscheck, Cell-penetrating HIV1 TAT peptides can generate pores in model membranes, Biophys. J. 99 (2010) 153-162.
30. P.A. Gurnev, S.T. Yang, K.C. Melikov, L.V. Chernomordik, S.M. Bezrukov, Cationic cell-penetrating peptide binds to planar lipid bilayers containing negatively charged lipids but does not induce conductive pores, Biophys. J. 104(2013) 1933-1939.
31. H.D. Herce, A.E. Garcia, J. Litt, R.S. Kane, P. Martin, N. Enrique, A. Rebolledo, V. Milesi, Arginine-rich peptides destabilize the plasma membrane, consistent with a pore formation translocation mechanism of cell-penetrating peptides, Biophys. J. 97 (2009) 1917-1925.
32. Y.C. Su, A.J. Waring, P. Ruchala, M. Hong, Membrane-bound dynamic structure ofan arginine-rich cell-penetrating peptide, the protein transduction domain of HIV Tat, from solid-state NMR, Biochemistry 49 (2010) 6009-6020.
33. S. Shojania, J.D. O'Neil, HIV-1 Tat is a natively unfolded protein-the solution conformation and dynamics of reduced HIV-1 Tat-(1-72) by NMR spectroscopy, J. Biol. Chem. 281 (2006) 8347-8356.
34. P. Bayer, M. Kraft, A. Ejchart, M. Westendorp, R. Frank, P. Rosch, Structural studies of Hiv-1 tat protein, J. Mol. Biol. 247 (1995) 529-535.
35. H.D. Herce, A.E. Garcia, Molecular dynamics simulations suggest a mechanism for translocation of the HIV-1 TAT peptide across lipid membranes, Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 20805-20810.
36. S. Yesylevskyy, S.J. Marrink, A.E. Mark, Alternative mechanisms for the interaction of the cell-penetrating peptides penetratin and the TAT peptide with lipid bilayers, Biophys.J. 97 (2009) 40-49.
37. E.D. Jarasch, C.E. Reilly, P. Comes, J. Kartenbeck, W.W. Franke, Isolation and characterization of nuclear membranes from calf and rat thymus, Hoppe Seylers Z. Physiol. Chem. 354 (1973) 974-986.
38. S.A. Tristram-Nagle, Preparation of oriented, fully hydrated lipid samples for structure determination using X-ray scattering, Methods Mol. Biol. 400 (2007) 63-75.
39. N. Kučerka, Y.F. Liu, N.J. Chu, H.I. Petrache, S. Tristram-Nagle, J.F. Nagle, Structure of fully hydrated fluid phase DMPC and DLPC lipid bilayers using X-ray scattering from oriented multilamellar arrays and from unilamellar vesicles, Biophys. J. 88 (2005) 2626-2637.
40. K. He, S.J. Ludtke, W.T. Heller, H.W. Huang, Mechanism of alamethicin insertion into lipid bilayers, Biophys. J. 71 (1996) 2669-2679.
41. S. Schick, L.R. Chen, E. Li, J. Lin, I. Koper, K. Hristova, Assembly of the M2 tetramer is strongly modulated by lipid chain length, Biophys. J. 99 (2010) 1810-1817.
42. Y.F. Liu, J.F. Nagle, Diffuse scattering provides material parameters and electron density profiles of biomembranes, Phys. Rev. E. 69 (2004) 040901-040904 (R).
43. Y. Lyatskaya, Y.F. Liu, S. Tristram-Nagle, J. Katsaras, J.F. Nagle, Method for obtaining structure and interactions from oriented lipid bilayers, Phys. Rev. E. 63 (2001) 0119071-0119079.
44. N. Kučerka, J.F. Nagle, J.N. Sachs, S.E. Feller, J. Pencer, A. Jackson, J. Katsaras, Lipid bilayer structure determined by the simultaneous analysis of neutron and X-ray scattering data, Biophys. J. 95 (2008) 2356-2367.
45. T.T. Mills, G.E.S. Toombes, S. Tristram-Nagle, D.M. Smilgies, G.W. Feigenson, J.F. Nagle, Order parameters and areas in fluid-phase oriented lipid membranes using wide angle X-ray scattering, Biophys. J. 95 (2008) 669-681.
46. T.T. Mills, S. Tristram-Nagle, F.A. Heberle, N.F. Morales, J. Zhao, J. Wu, G.E.S. Toombes, J.F. Nagle, G.W. Feigenson, Liquid-liquid domains in bilayers detected by wide angle X-ray scattering, Biophys. J. 95 (2008) 682-690.
47. M. Raghunathan, Y. Zubovski, R.M. Venable, R.W. Pastor, J.F. Nagle, S. Tristram-Nagle, Structure and elasticity of lipid membranes with genistein and daidzein bioflavinoids using X-ray scattering and MD simulations, J. Phys. Chem. B 116 (2012) 3918-3927.
48. A.L. Boscia, K. Akabori, Z. Benamram, J.A. Michel, M.S. Jablin, J.D. Steckbeck, R.C. Montelaro, J.F. Nagle, S. Tristram-Nagle, Membrane structure correlates to function of LLP2 on the cytoplasmic tail of HIV-1 gp41 protein, Biophys. J. 105 (2013) 657-666.
49. B. Hess, C. Kutzner, D. van der Spoel, E. Lindahl, GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation, J. Chem. Theory Comput 4(2008)435-447.
50. J.P. Jambeck A.P. Lyubartsev, Derivation and systematic validation of a refined all-atom force field for phosphatidylcholine lipids, J. Phys. Chem. B 116 (2012) 3164-3179.
51. J.P.M. Jambedc, A.P. Lyubartsev, An extension and further validation of an all-atomistic force field for biological membranes, J. Chem. Theory Comput. 8 (2012) 2938-2948.
52. V. Hornak, R. Abel, A. Okur, B. Strockbine, A. Roitberg, C. Simmerling, Comparison of multiple amber force fields and development of improved protein backbone parameters, Proteins 65 (2006) 712-725.
53. W.L. Jorgensen, J. Chandrasekhar, J.D. Madura, R.W. Impey, M.L. Klein, Comparison of simple potential functions for simulating liquid water, J. Chem. Phys. 79 (1983) 926-935.
54. N. Kučerka, J. Katsaras, J.F. Nagle, Comparing membrane simulations to scattering experiments: introducing the SIMtoEXP software, J. Membr. Biol. 235 (2010) 43-50.
55. N. Kučerka, S. Tristram-Nagle, J.F. Nagle, Closer look at structure of fully hydrated fluid phase DPPC bilayers, Biophys. J. 90 (2006) L83-L85.
56. N. Kučerka, S. Tristram-Nagle, J.F. Nagle, Structure of fully hydrated fluid phase lipid bilayers with monounsaturated chains, J. Membr. Biol. 208 (2005) 193-202.
57. J. Pan, D.P. Tieleman, J.F. Nagle, N. Kucerka, S. Tristram-Nagle, Alamethicin in lipid bilayers: combined use of X-ray scattering and MD simulations, Biochim. Biophys. Acta 1788 (2009) 1387-1397.
58. S. Tristram-Nagle, C.P. Yang, J.F. Nagle, Thermodynamic studies ofpurple membrane, Biochim. Biophys. Acta 854 (1986) 58-66.
59. A.C.V. Johansson, E. Lindahl, The role of lipid composition for insertion and stabilization of amino acids in membranes, J. Chem. Phys. 130 (2009).
60. S. Tristram-Nagle, J.F. Nagle, HIV-1 fusion peptide decreases bending energy and promotes curved fusion intermediates, Biophys. J. 93 (2007) 2048-2055.
61. M. Vazdar, E. Wernersson, M. Khabiri, L. Cwiklik P. Jurkiewicz, M. Hof, E. Mann, S. Kolusheva, R. Jelinek, P. Jungwirth, Aggregation of oligoarginines at phospholipid membranes: molecular dynamics simulations, time-dependent fluorescence shift, and biomimetic colorimetri: assays, J. Phys. Chem. B 117 (2013) 11530-11540.
62. Z. Wu, Q. Cui, A. Yethiraj, Why do arginine and lysine organize lipids differently? Insights from coarse-grained and atomistic simulations, J. Phys. Chem. B 117 (2013) 12145-12156.
63. L.B. Li, I. Vorobyov, T.W. Allen, Potential of mean force and pK(a) profile calculation for a lipid membrane-exposed arginine side chain, J. Phys. Chem. B 112 (2008) 9574-9587.
64. I. Vorobyov, L.B. Li, T.W. Allen, Assessing atomistic and coarse-grained force fields for protein-lipid interactions: the formidable challenge of an ionizable side chain in a membrane, J. Phys. Chem. B 112 (2008) 9588-9602.
65. J.L. MacCallum, W.F.D. Bennett, D.P. Tieleman, Distribution of amino acids in a lipid bilayer from computer simulations, Biophys. J. 94 (2008) 3393-3404.
66. E.V. Schow, J.A. Freites, P. Cheng, A. Bernsel, G. von Heijne, S.H. White, D.J. Tobias, Arginine in membranes: the connection between molecular dynamics simulations and translocon-mediated insertion experiments, J. Membr. Biol. 239 (2011) 35-48.
67. W.C. Wimley, T.P. Creamer, S.H. White, Solvation energies of amino acid side chains and backbone in a family of host-guest pentapeptides, Biochemistry 35 (1996) 5109-5124.
68. W.C. Wimley, S.H. White, Experimentally determined hydrophobicity scale for proteins at membrane interfaces, Nat. Struct. Biol. 3 (1996) 842-848.
69. B. Roux, Lonely arginine seeks friendly environment, J. Gen. Physiol. 130 (2007) 233-236.
70. N. Sreerama, R.W. Woody, Structural composition ofbeta(I)-and beta(II)-proteins, Protein Sci. 12 (2003) 384-388.
71. W. Kabsch, C. Sander, Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features, Biopolymers 22 (1983) 2577-2637.
72. A. Mishra, V.D. Gordon, L.H. Yang, R. Coridan, G.C.L. Wong, HIV TAT forms pores in membranes by inducing saddle-splay curvature: potential role of bidentate hydrogen bonding, Angew. Chem. Int. Ed. 47 (2008) 2986-2989.
73. D. Choi, J.H. Moon, H. Kim, B.J. Sung, M.W. Kim, G.Y. Tae, S.K. Satija, B. Akgun, C.J. Yu, H.W. Lee, D.R. Lee, J.M. Henderson, J.W. Kwong, K.L Lam, K.Y.C. Lee, K. Shin, Insertion mechanism of cell-penetrating peptides into supported phospholipid membranes revealed by X-ray and neutron reflection, Soft Matter 8 (2012) 8294-8297.
74. A. Ziegler, X.L. Blatter, A. Seelig, J. Seelig, Protein transduction domains of HIV-1 and SIV TAT interact with charged lipid vesicles. Binding mechanism and thermodynamic analysis, Biochemistry 42 (2003) 9185-9194.
75. K. Huang, A.E. Garcia, Free energy of translocating an arginine-rich cell-penetrating peptide across a lipid bilayer suggests pore formation, Biophys. J. 104 (2013) 412-420.